联环药业: 联环药业董事会薪酬与考核委员会工作细则(2025年8月修订)

Core Points - The article outlines the establishment and operational guidelines of the Compensation and Assessment Committee of Jiangsu Lianhuan Pharmaceutical Co., Ltd, aimed at improving the governance structure and management of compensation for directors and senior management [1][2] Group 1: General Provisions - The Compensation and Assessment Committee is a specialized body established by the board of directors to formulate assessment standards and compensation policies for directors and senior management [1] - The committee consists of three to five members, with a majority being independent directors [2] Group 2: Responsibilities and Authority - The committee is responsible for creating compensation plans based on the roles and responsibilities of directors and senior management, including performance evaluation standards and reward systems [9] - It reviews the performance of directors and senior management and supervises the execution of the company's compensation system [9] Group 3: Decision-Making Procedures - The committee's working group prepares necessary materials for decision-making, including financial indicators and performance evaluations of directors and senior management [5][14] - The committee conducts performance evaluations and proposes compensation amounts and reward methods to the board of directors for approval [14] Group 4: Meeting Rules - The committee meets as needed, with a requirement for two-thirds of members to be present for decisions to be valid [15] - Meetings can be held in person or via other communication methods, and decisions require a majority vote [17] Group 5: Miscellaneous Provisions - The guidelines will be implemented upon approval by the board of directors and will be subject to relevant laws and regulations [25][26] - The board of directors holds the authority to interpret these guidelines [27]